CIK 1559565
Long positions in SEC Section 13(f) securities (US-listed stocks, ADRs and ETFs), largest first · Δ vs 2017-Q3. A lagged quarterly snapshot (filed ≤45 days after quarter-end); excludes shorts, options, cash, and shares listed only on non-US exchanges — foreign companies held via a US listing or ADR (e.g. Alibaba, TSMC) ARE included.
As filed = each book applied at its quarter-end (what the reported book did) · As copyable = applied at its statutory 45-day filing deadline (what a 13F follower could have earned).
Computing…
Hypothetical modeled performance constructed with hindsight — not actual results, and not indicative of future results. See the Disclaimer.
| Industry group | Weight | Names |
|---|---|---|
| Pharmaceuticals & Biotechnology | 51.05% | 4 |
| Unclassified | 41.34% | 3 |
| Health Care Providers & Services | 7.61% | 1 |
| # | Ticker | Name | Sector | Weight |
|---|---|---|---|---|
| 1 | NCNA | NuCana plc | Health Care | 25.76% |
| 2 | OBSEVA SA | Unclassified | 25.31% | |
| 3 | ACRS | Aclaris Therapeutics, Inc. | Health Care | 20.72% |
| 4 | SPARK THERAPEUTICS INC | Unclassified | 13.51% | |
| 5 | NTRA | Natera, Inc. | Health Care | 7.61% |
| 6 | AURIS MED HLDG AG | Unclassified | 2.52% | |
| 7 | OCGN | Ocugen, Inc. | Health Care | 2.32% |
| 8 | SYBX | SYNLOGIC, INC. | Health Care | 2.25% |
5/8 names classified · sector 58.7% of weight · industry 58.7% · mkt cap 32.9%; unclassified names shown, never dropped.
Sector is classified on each name's CURRENT fundamentals, not point-in-time — apparent sector drift can reflect the market re-rating a holding, not a manager trade. 13F is a lagged quarterly snapshot of long positions in US-listed securities only — foreign companies held via a US listing or ADR ARE included, but shares listed only on non-US exchanges (plus shorts, options and cash) are not. Latest quarter: 58.7% of the book is sector-classified (unclassified names shown, never dropped).
Only 0% of book weight classified — the grid is NOT representative of the whole book.
Classified: 0.0% of book weight (0/6 names) · unclassified 100.0%: , NCNA, ACRS, NTRA, OCGN, SYBX. Size: cap 70/20/10 bands; style: value/growth composite on our own metrics — not Morningstar's model.
No contribution data for this period.
| # | Security | Shares | Value | Weight | Δ QoQ |
|---|---|---|---|---|---|
| 1 | NCNANUCANA PLC | 4,666,666 | $47M | 25.8% | ADD 600% |
| 2 | OBSEVA SA | 4,749,623 | $46M | 25.3% | ADD 27% |
| 3 | ACRSACLARIS THERAPEUTICS INC | 1,539,480 | $38M | 20.7% | HOLD |
| 4 | SPARK THERAPEUTICS INC | 481,270 | $25M | 13.5% | HOLD |
| 5 | NTRANATERA INC | 1,550,280 | $14M | 7.6% | HOLD |
| 6 | AURIS MED HLDG AG | 7,818,175 | $5M | 2.5% | HOLD |
| 7 | OCGNOcugen | 2,077,040 | $4M | 2.3% | HOLD |
| 8 | SYBXSYNLOGIC INC | 424,972 | $4M | 2.3% | HOLD |
Where this firm's principals came from and which firms its alumni went on to found.
